Details of the Drug
General Information of Drug (ID: DMAI83D)
| Drug Name | 
                     Voxilaprevir 
                 | 
            |||||
|---|---|---|---|---|---|---|
| Synonyms | Voxilaprevir; Voxilaprevir (USAN/INN); Voxilaprevir [USAN:INN]; 0570F37359;J3.665.048F; 1535212-07-7; CS-0017027; D10899; DB12026; GS-9857; HY-19840; L9P; SCHEMBL15412621; UNII-0570F37359 | |||||
| Affected Organisms | 
                     Hepatitis C Virus 
                 | 
            |||||
| Structure | 
                    ![]()  | 
            |||||
| 3D MOL is unavailable | 2D MOL | |||||
| #Ro5 Violations (Lipinski): 3 | Molecular Weight (mw) | 868.9 | ||||
| Logarithm of the Partition Coefficient (xlogp) | 5.9 | |||||
| Rotatable Bond Count (rotbonds) | 9 | |||||
| Hydrogen Bond Donor Count (hbonddonor) | 3 | |||||
| Hydrogen Bond Acceptor Count (hbondacc) | 15 | |||||
| Chemical Identifiers | 
                        
  | 
                |||||
| Cross-matching ID | ||||||
| Combinatorial Drugs (CBD) | Click to Jump to the Detailed CBD Information of This Drug | |||||
Molecular Interaction Atlas of This Drug
![]() Drug Transporter (DTP)  | 
                
                    
  | 
            |||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
![]() Drug-Metabolizing Enzyme (DME)  | 
                
                    
  | 
            |||||||||||||||||||||||||||||||
| Molecular Interaction Atlas (MIA) | ||||||||||||||||||||||||||||||||



